These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32134701)

  • 41. Liquid biopsy assay for lung carcinoma using centrifuged supernatants from fine-needle aspiration specimens.
    Hannigan B; Ye W; Mehrotra M; Lam V; Bolivar A; Zalles S; Barkoh BA; Duose D; Hu PC; Broaddus R; Stewart J; Heymach J; Medeiros LJ; Wistuba I; Luthra R; Roy-Chowdhuri S
    Ann Oncol; 2019 Jun; 30(6):963-969. PubMed ID: 30887015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving Patient Care by Incorporation of Multidisciplinary Breast Radiology-Pathology Correlation Conference.
    Prakash S; Venkataraman S; Slanetz PJ; Dialani V; Fein-Zachary V; Littlehale N; Mehta TS
    Can Assoc Radiol J; 2016 May; 67(2):122-9. PubMed ID: 26632099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent innovations in the USA National Cancer Institute-sponsored investigator initiated Phase I and II anticancer drug development.
    Bando H; Takebe N
    Jpn J Clin Oncol; 2015 Nov; 45(11):1001-6. PubMed ID: 26423340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of endobronchial needle aspiration with forceps and brush biopsies in the diagnosis of endobronchial lung cancer.
    Bilaçeroğlu S; Günel O; Cağirici U; Perim K
    Monaldi Arch Chest Dis; 1997 Feb; 52(1):13-7. PubMed ID: 9151514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The First National Pain Medicine Summit--final summary report.
    Lippe PM; Brock C; David J; Crossno R; Gitlow S
    Pain Med; 2010 Oct; 11(10):1447-68. PubMed ID: 21199301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A risk-management approach for effective integration of biomarkers in clinical trials: perspectives of an NCI, NCRI, and EORTC working group.
    Hall JA; Salgado R; Lively T; Sweep F; Schuh A
    Lancet Oncol; 2014 Apr; 15(4):e184-93. PubMed ID: 24694642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improving the Time to Activation of New Clinical Trials at a National Cancer Institute-Designated Comprehensive Cancer Center.
    Williams E; Brown TJ; Griffith P; Rahimi A; Oilepo R; Hammers H; Laetsch TW; Currykosky P; Partridge S; Beg MS
    JCO Oncol Pract; 2020 Apr; 16(4):e324-e332. PubMed ID: 32048941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A national cancer clinical trials system for targeted therapies.
    Mendelsohn J
    Sci Transl Med; 2011 Mar; 3(75):75cm8. PubMed ID: 21430266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.
    Al-Hallaq HA; Chmura S; Salama JK; Winter KA; Robinson CG; Pisansky TM; Borges V; Lowenstein JR; McNulty S; Galvin JM; Followill DS; Timmerman RD; White JR; Xiao Y; Matuszak MM
    Pract Radiat Oncol; 2016; 6(6):e291-e298. PubMed ID: 27345129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is there room for improvement in adverse event reporting in the era of targeted therapies?
    Edgerly M; Fojo T
    J Natl Cancer Inst; 2008 Feb; 100(4):240-2. PubMed ID: 18270340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.
    Tsao AS; Lindwasser OW; Adjei AA; Adusumilli PS; Beyers ML; Blumenthal GM; Bueno R; Burt BM; Carbone M; Dahlberg SE; de Perrot M; Fennell DA; Friedberg J; Gill RR; Gomez DR; Harpole DH; Hassan R; Hesdorffer M; Hirsch FR; Hmeljak J; Kindler HL; Korn EL; Liu G; Mansfield AS; Nowak AK; Pass HI; Peikert T; Rimner A; Robinson BWS; Rosenzweig KE; Rusch VW; Salgia R; Sepesi B; Simone CB; Sridhara R; Szlosarek P; Taioli E; Tsao MS; Yang H; Zauderer MG; Malik SM
    J Thorac Oncol; 2018 Nov; 13(11):1655-1667. PubMed ID: 30266660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Infrastructure of cancer clinical trial cooperative groups in western countries].
    Fukuda H
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1144-51. PubMed ID: 10945009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Feasibility of in situ, high-resolution correlation of tracer uptake with histopathology by quantitative autoradiography of biopsy specimens obtained under 18F-FDG PET/CT guidance.
    Fanchon LM; Dogan S; Moreira AL; Carlin SA; Schmidtlein CR; Yorke E; Apte AP; Burger IA; Durack JC; Erinjeri JP; Maybody M; Schöder H; Siegelbaum RH; Sofocleous CT; Deasy JO; Solomon SB; Humm JL; Kirov AS
    J Nucl Med; 2015 Apr; 56(4):538-44. PubMed ID: 25722446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perspectives on research activity in the USA on Cancer Precision Medicine.
    Bando H; Takebe N
    Jpn J Clin Oncol; 2016 Feb; 46(2):106-10. PubMed ID: 26531706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High yield of same-session EUS-guided liver biopsy by 19-gauge FNA needle in patients undergoing EUS to exclude biliary obstruction.
    Stavropoulos SN; Im GY; Jlayer Z; Harris MD; Pitea TC; Turi GK; Malet PF; Friedel DM; Grendell JH
    Gastrointest Endosc; 2012 Feb; 75(2):310-8. PubMed ID: 22248599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials.
    Meropol NJ; Wong YN; Albrecht T; Manne S; Miller SM; Flamm AL; Benson AB; Buzaglo J; Collins M; Egleston B; Fleisher L; Katz M; Kinzy TG; Liu TM; Margevicius S; Miller DM; Poole D; Roach N; Ross E; Schluchter MD
    J Clin Oncol; 2016 Feb; 34(5):469-78. PubMed ID: 26700123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce.
    Friedberg JS; Culligan MJ; Tsao AS; Rusch V; Sepesi B; Pass HI; Bueno R; Burt B; Sugarbaker DJ; de Perrot M; Adjei AA; Adusumilli PS; Hirsch FR; Malik SM; Harpole DJ
    J Thorac Oncol; 2019 Aug; 14(8):1343-1353. PubMed ID: 31136816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non--Small-Cell Lung Cancer.
    Kitazono S; Fujiwara Y; Tsuta K; Utsumi H; Kanda S; Horinouchi H; Nokihara H; Yamamoto N; Sasada S; Watanabe S; Asamura H; Tamura T; Ohe Y
    Clin Lung Cancer; 2015 Sep; 16(5):385-90. PubMed ID: 25937270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Consensus minimum data set for lung cancer multidisciplinary teams: Results of a Delphi process.
    Stone E; Rankin N; Phillips J; Fong K; Currow DC; Miller A; Largey G; Zielinski R; Flynn P; Shaw T
    Respirology; 2018 Oct; 23(10):927-934. PubMed ID: 29641841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.